Amylin Pharmaceuticals
Latest Amylin Pharmaceuticals News
-
Health Highlights: Jan. 13, 2010
misleading materials. Among the specific concerns cited by the FDA, according to Dow Jones : Representatives of Amylin Pharmaceuticals and Eli Lilly exaggerated the ability of the diabetes drug Byetta to help patients lose weight. A print ad for
-
FDA Issues Warning for Diabetes Drug
these symptoms to immediately consult with a health-care professional. Byetta, made by San Diego-based Amylin Pharmaceuticals Inc ., is used to control blood sugar levels. Nausea, vomiting and diarrhea are the most common side effects
-
Curbing Obesity Epidemic Key to Health Care Reform: Experts
public and private organizations. The alliance is funded by drug makers Sanofi-Aventis U.S. L.L.C. and Amylin Pharmaceuticals . Former Surgeon General Dr. David Satcher, whose 2001 report on obesity recognized the problem as an "epidemic
-
Diabetes Drug Byetta May Aid Weight Loss in Obese Patients
Society in Washington, D.C. Previous research has shown that exenatide, an injectable medication marketed by Amylin Pharmaceuticals and Eli Lilly and Company under the brand name Byetta, can help lower blood sugar and helps some diabetics lose
-
Health Highlights: May 5, 2009
injectable diabetes drug exenatide LAR has been submitted to the U.S. Food and Drug Administration for approval, Amylin Pharmaceuticals Inc . said Tuesday. The drug is an extended version of the twice-daily injectable drug Byetta, the Associated
-
New Diabetes Drug Works Well in Trial
S. market. The first is exenatide (Byetta), which was approved by the FDA in 2005. It is marketed by Amylin Pharmaceuticals and Eli Lilly. It is taken by injection twice a day, while liraglutide requires only one daily injection
News
-
Once-Weekly Diabetes Drug Boosts Blood Sugar Control
heels of less-heartening news about Byetta (exenatide). On Aug. 26, the drug's makers, Eli Lilly and Amylin Pharmaceuticals Inc ., reported the pancreatitis-linked deaths of four people who'd been taking the medication. That news
-
4 More Deaths Reported Among Byetta Patients
the medication. The announcement by Eli Lilly and Amylin Pharmaceuticals Inc . came a week after the U.S. Food and Drug Administration to better understand the suspected relationship Amylin and Lilly continue to pursue a comprehensive drug-safety
-
Health Highlights: Aug. 18, 2008
resulted from six recent cases of pancreatitis among users of the diabetes drug Byetta, marketed by drug makers Amylin Pharmaceuticals and Eli Lilly & Co., the U.S. Food and Drug Administration said Monday. The other four pancreatitis patients
-
Weekly Drug Helps Type 2 Diabetics
occurred in patients using sulfonylurea therapy. Amylin Pharmaceuticals Inc ., the maker of Byetta, is working with Eli Association has more about diabetes . SOURCE: Amylin Pharmaceuticals Inc ., Eli Lilly and Co., Alkermes Inc., news
-
Health Highlights: Oct. 17, 2007
Byetta was approved for sale in the U.S. in 2005. The drug is marketed by Amylin Pharmaceuticals Inc . of San Diego and Eli Lilly & Co. of Indianapolis. Amylin has agreed to update Byetta's label to provide clear advice on the signs and
-
Gila Monster Spit Could Be a Weight-Loss Hit
September. The study was funded by two drug companies -- Amylin Pharmaceuticals and Eli Lilly and Company -- collaborating on the the researchers involved with this study work for Amylin or Eli Lilly. Exenatide was approved by the U.S
-
Microsoft Plans Service Pack for Office Project 2007
customers have been waiting for SP1 before deploying it. Christopher Ludlow, director of project management at Amylin Pharmaceuticals , in San Diego, said he is waiting for SP1 before migrating to Project 2007. The system integrator he works
